Biomarkers for Prediction of Tumor Response to Radiotherapy
ConditionSolid Tumors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorChuangzhen Chen
About this trial
This study aims to explore potential biomarkers for prediction of therapeutic outcomes in patients with solid tumors after radiotherapy
Eligibility criteria
Qualifiers
Pathological proven diagnosis of solid tumors
Tumor accessible for biopsy during the course of radiotherapy or tumor samples could be obtained via surgery
Patient must provide study-specific informed consent prior to study entry
Disqualifiers
History of autoimmune diseases
History of immunotherapy
Prior radiation therapy that would result in overlap of planned radiation therapy fields
Will receive immunotherapy during the course of radiotherapy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Chuangzhen Chen
Lead sponsor
Shantou University Medical College
Sponsor institution
University of Oxford
Collaborator
Source ClinicalTrials.gov